Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients. [electronic resource]
Producer: 20091117Description: 724-31 p. digitalISSN:- 1365-2893
- Age Factors
- Antiviral Agents -- therapeutic use
- Female
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Secondary Prevention
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.